Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High?

Haemonetics (HAE) closed the last trading session at $85.26, gaining 13.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $109 indicates a 27.8% upside potential.The average comprises eight short-term price targets ranging from a low of $85 to a high of $125, with a standard deviation of $13.11. While the lowest estimate indicates a decline of 0.3% from the current price level, th ...